Shopping Cart
Remove All
Your shopping cart is currently empty
Taprizosin(UK-338003) is a selective and orally active α1-adrenoceptor antagonist for vasodilatation in the treatment of benign prostatic hyperplasia.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $373 | In Stock | In Stock | |
| 5 mg | $896 | In Stock | In Stock | |
| 10 mg | $1,230 | In Stock | In Stock | |
| 25 mg | $1,880 | In Stock | In Stock | |
| 50 mg | $2,580 | In Stock | In Stock | |
| 100 mg | $3,400 | In Stock | In Stock |
| Description | Taprizosin(UK-338003) is a selective and orally active α1-adrenoceptor antagonist for vasodilatation in the treatment of benign prostatic hyperplasia. |
| Synonyms | UK-338003, UK338003, UK-338,003, UK 338003, Taprizosin Mesylate |
| Molecular Weight | 506.58 |
| Formula | C25H26N6O4S |
| Cas No. | 210538-44-6 |
| Smiles | NC=1C=2C(=C(OC)C(OC)=CC2N=C(N1)N3CC=4C(CC3)=C(NS(C)(=O)=O)C=CC4)C5=CC=CC=N5 |
| Relative Density. | 1.401g/cm3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 60 mg/mL (118.44 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.